Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...